Deler fremragende | 112,873,552 shares |
Insideraktier | 161.383.910 shares |
Total Insiders | 17 |
Insider-stemningsscore
Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.
Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.
Opdateringsfrekvens: Dagligt
Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.
Officers sentiment score
Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.
Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.
Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.
Opdateringsfrekvens: Dagligt
Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.
Nøgle Insider Metrics
Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.
For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).
Insiderhandelsdiagram
Vaxxinity, Inc. insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.
Insiderliste og lønsomhedsmålinger
Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.
See our leaderboard of most profitable insider traders.
Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
---|---|---|---|
Gregory R Blatt Director - [D] | 76.923 | 76.923 | |
James Chui Director - [D] | 14.000 | 14.000 | |
Peter Diamandis Director - [D] | 2.019.880 | 2.019.880 | |
Martin Doran See Remarks - [O] | 22.688 | 22.688 | |
Farshad Guirakhoo (Former) Chief Scientific Off. - [O] | 68.645 | 68.645 |
Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
---|---|---|---|
George R Hornig | 67.953 | ||
Mei Mei Hu
See Remarks, Director, 10% Owner -
[D]
[O]
|
51.737.344 | 51.737.344 | |
Landon E Ogilvie Director - [D] | 32.850 | 32.850 | |
Ulo Palm Chief Medical Officer - [O] | 450 | 450 | |
Molina Rene Paula | 96.153 | ||
Jason Pesile | 51.225 |
Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
---|---|---|---|
Peter Powchik Director - [D] | 225.858 | 225.858 | |
Prime Movers Lab Fund I LP
10% Owner -
|
3.594.122 | 3.594.122 | |
Lou Reese
Executive Chairman, Director, 10% Owner -
[D]
[O]
|
51.737.344 | 51.737.344 | |
Dakin Sloss
10% Owner -
|
9.738.192 | 3.594.122 | |
James Alan Smith Director - [D] | 116.462 | 116.462 | |
United Biomedical Inc
10% Owner -
|
51.737.344 | 51.737.344 |
Report errors via our new Insider Auditing Tool
Track Records af insiderkøb - Kortsigtet profitanalyse
I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i VAXX / Vaxxinity, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Track Records af insidersalg - Kortsigtet tabsanalyse
I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i VAXX / Vaxxinity, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Transaktionshistorik
Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.
Fil Dato |
Handle Dato |
Form | Insider | Ticker | Sikkerhedstitel | Kode | Direkte | Dyrke motion Pris |
Enhed Pris |
Enheder Ændret |
Værdi Ændret (1K) |
Tilbage Muligheder |
Tilbage Aktier |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023-09-08 | 2023-09-08 | 4 | Prime Movers Lab Fund I LP Held by Prime Movers Growth Fund 1 LP | VAXX | Class A common stock | I | 1,6700 | -10.349 | -17 | 3.594.122 | ||||
2023-09-08 | 2023-09-08 | 4 | Prime Movers Lab Fund I LP Held by COVAXX PML SPV 3 LP | VAXX | Class A common stock | I | 1,6700 | -4.217 | -7 | 1.464.578 | ||||
2023-09-08 | 2023-09-08 | 4 | Prime Movers Lab Fund I LP Held by COVAXX PML SPV 2 LP | VAXX | Class A Common Stock | I | 1,6700 | -2.395 | -4 | 831.658 | ||||
2023-09-08 | 2023-09-08 | 4 | Prime Movers Lab Fund I LP | VAXX | Class A common stock | D | 1,6700 | -25.089 | -42 | 8.713.663 | ||||
2023-09-08 | 2023-09-08 | 4 | Prime Movers Lab Fund I LP Held by COVAXX PML SPV 1 LP | VAXX | Class A common stock | I | 1,6700 | -5.911 | -10 | 2.053.079 | ||||
2023-09-08 | 2023-09-07 | 4 | Prime Movers Lab Fund I LP Held by Prime Movers Growth Fund 1 LP | VAXX | Class A common stock | I | 1,7872 | -8.378 | -15 | 3.604.471 | ||||
2023-09-08 | 2023-09-07 | 4 | Prime Movers Lab Fund I LP Held by COVAXX PML SPV 3 LP | VAXX | Class A common stock | I | 1,7872 | -3.413 | -6 | 1.468.795 | ||||
2023-09-08 | 2023-09-07 | 4 | Prime Movers Lab Fund I LP Held by COVAXX PML SPV 2 LP | VAXX | Class A Common Stock | I | 1,7872 | -1.939 | -3 | 834.053 | ||||
2023-09-08 | 2023-09-07 | 4 | Prime Movers Lab Fund I LP | VAXX | Class A Common Stock | D | 1,7872 | -20.312 | -36 | 8.738.752 | ||||
2023-09-08 | 2023-09-07 | 4 | Prime Movers Lab Fund I LP Held by COVAXX PML SPV 1 LP | VAXX | Class A Common Stock | I | 1,7872 | -4.786 | -9 | 2.058.990 | ||||
2023-09-08 | 2023-09-06 | 4 | Prime Movers Lab Fund I LP Held by Prime Movers Growth Fund 1 LP | VAXX | Class A Common Stock | I | 1,8823 | -2.189 | -4 | 3.612.849 | ||||
2023-09-08 | 2023-09-06 | 4 | Prime Movers Lab Fund I LP Held by COVAXX PML SPV 3 LP | VAXX | Class A Common Stock | I | 1,8823 | -892 | -2 | 1.472.208 | ||||
2023-09-08 | 2023-09-06 | 4 | Prime Movers Lab Fund I LP Held by COVAXX PML SPV 2 LP | VAXX | Class A Common Stock | I | 1,8823 | -507 | -1 | 835.992 | ||||
2023-09-08 | 2023-09-06 | 4 | Prime Movers Lab Fund I LP | VAXX | Class A Common Stock | D | 1,8823 | -5.308 | -10 | 8.759.064 | ||||
2023-09-08 | 2023-09-06 | 4 | Prime Movers Lab Fund I LP Held by COVAXX PML SPV 1 LP | VAXX | Class A Common Stock | I | 1,8823 | -1.251 | -2 | 2.063.776 | ||||
2023-05-02 | 2023-04-26 | 4 | Diamandis Peter | VAXX | Class A common stock | D | 1,2100 | 46.500 | 56 | 906.141 | ||||
2023-05-02 | 2023-04-26 | 4 | Diamandis Peter | VAXX | Class A common stock | D | 0,5700 | 429.037 | 245 | 859.641 | ||||
2023-04-28 | 3/A | Smith James Alan By IO Fund, LLC | VAXX | Class A common stock | I | 54.202 | ||||||||
2023-04-28 | 3/A | Smith James Alan | VAXX | Class A common stock | D | 8.058 | ||||||||
2023-02-10 | 3 | Smith James Alan | VAXX | Class A common stock | D | 8.058 | ||||||||
2023-02-10 | 3 | Smith James Alan By IO Fund, LLC | VAXX | Class A common stock | I | 12.268 | ||||||||
2023-02-10 | 3 | Ogilvie Landon E By child | VAXX | Class A common stock | I | 32.850 | ||||||||
2023-01-25 | 2023-01-23 | 4 | Prime Movers Lab Fund I LP | VAXX | Class A common stock | D | 3,3514 | -405.217 | -1.358 | 8.764.372 | ||||
2023-01-25 | 2023-01-23 | 4 | Prime Movers Lab Fund I LP Held by COVAXX PML SPV 1 LP | VAXX | Class A common stock | I | 3,3514 | -95.475 | -320 | 2.065.027 | ||||
2022-12-05 | 2022-12-02 | 4 | Prime Movers Lab Fund I LP | VAXX | Class A Common Stock | D | 2,5682 | -11.121 | -29 | 9.169.589 | ||||
2022-12-05 | 2022-12-02 | 4 | Prime Movers Lab Fund I LP Held by COVAXX PML SPV 1 LP | VAXX | Class A Common Stock | I | 2,5682 | -2.620 | -7 | 2.160.502 | ||||
2022-12-05 | 2022-12-01 | 4 | Prime Movers Lab Fund I LP | VAXX | Class A Common Stock | D | 2,9717 | -270.964 | -805 | 9.180.710 | ||||
2022-12-05 | 2022-12-01 | 4 | Prime Movers Lab Fund I LP Held by COVAXX PML SPV 1 LP | VAXX | Class A Common Stock | I | 2,9717 | -63.843 | -190 | 2.163.122 | ||||
2022-09-08 | 2022-09-06 | 4 | Prime Movers Lab Fund I LP | VAXX | Class A Common Stock | D | 2,4029 | -25.243 | -61 | 9.451.674 | ||||
2022-09-08 | 2022-09-06 | 4 | Prime Movers Lab Fund I LP Held by COVAXX PML SPV 3 LP | VAXX | Class A Common Stock | I | 2,4029 | -3.934 | -9 | 1.473.100 | ||||
2022-09-08 | 2022-09-06 | 4 | Prime Movers Lab Fund I LP Held by COVAXX PML SPV 2 LP | VAXX | Class A Common Stock | I | 2,4029 | -2.234 | -5 | 836.499 | ||||
2022-09-08 | 2022-09-06 | 4 | Prime Movers Lab Fund I LP Held by COVAXX PML SPV 1 LP | VAXX | Class A Common Stock | I | 2,4029 | -5.947 | -14 | 2.226.965 | ||||
2022-08-29 | 2022-08-22 | 4 | Guirakhoo Farshad | VAXX | Class A common stock | D | 0,5700 | 2.640 | 2 | 68.645 | ||||
2022-08-29 | 2022-08-15 | 4 | Guirakhoo Farshad | VAXX | Class A common stock | D | 0,5700 | 26.005 | 15 | 66.005 | ||||
2022-08-29 | 2022-07-29 | 4 | Guirakhoo Farshad | VAXX | Class A common stock | D | 0,5700 | 20.000 | 11 | 40.000 | ||||
2022-08-29 | 2022-01-13 | 4 | Guirakhoo Farshad | VAXX | Class A common stock | D | 0,5700 | 10.000 | 6 | 10.000 | ||||
2022-08-25 | 2022-08-25 | 4 | Prime Movers Lab Fund I LP | VAXX | Class A common stock | D | 2,3310 | -22.757 | -53 | 9.476.917 | ||||
2022-08-25 | 2022-08-25 | 4 | Prime Movers Lab Fund I LP Held by COVAXX PML SPV 3 LP | VAXX | Class A common stock | I | 2,3310 | -3.547 | -8 | 1.477.034 | ||||
2022-08-25 | 2022-08-25 | 4 | Prime Movers Lab Fund I LP Held by COVAXX PML SPV 2 LP | VAXX | Class A common stock | I | 2,3310 | -2.014 | -5 | 838.733 | ||||
2022-08-25 | 2022-08-25 | 4 | Prime Movers Lab Fund I LP Held by COVAXX PML SPV 1 LP | VAXX | Class A common stock | I | 2,3310 | -5.362 | -12 | 2.232.912 | ||||
2022-08-25 | 2022-08-24 | 4 | Prime Movers Lab Fund I LP | VAXX | Class A Common Stock | D | 2,3862 | -83.786 | -200 | 9.499.674 | ||||
2022-08-25 | 2022-08-24 | 4 | Prime Movers Lab Fund I LP Held by COVAXX PML SPV 3 LP | VAXX | Class A Common Stock | I | 2,3862 | -13.058 | -31 | 1.480.581 | ||||
2022-08-25 | 2022-08-24 | 4 | Prime Movers Lab Fund I LP Held by COVAXX PML SPV 2 LP | VAXX | Class A Common Stock | I | 2,3862 | -7.415 | -18 | 840.747 | ||||
2022-08-25 | 2022-08-24 | 4 | Prime Movers Lab Fund I LP Held by COVAXX PML SPV 1 LP | VAXX | Class A Common Stock | I | 2,3862 | -19.741 | -47 | 2.238.274 | ||||
2022-08-25 | 2022-08-23 | 4 | Prime Movers Lab Fund I LP | VAXX | Class A Common Stock | D | 2,4466 | -33.785 | -83 | 9.583.460 | ||||
2022-08-25 | 2022-08-23 | 4 | Prime Movers Lab Fund I LP Held by COVAXX PML SPV 3 LP | VAXX | Class A Common Stock | I | 2,4466 | -5.265 | -13 | 1.493.639 | ||||
2022-08-25 | 2022-08-23 | 4 | Prime Movers Lab Fund I LP Held by COVAXX PML SPV 2 LP | VAXX | Class A Common Stock | I | 2,4466 | -2.990 | -7 | 848.162 | ||||
2022-08-25 | 2022-08-23 | 4 | Prime Movers Lab Fund I LP Held by COVAXX PML SPV 1 LP | VAXX | Class A Common Stock | I | 2,4466 | -7.960 | -19 | 2.258.015 | ||||
2022-06-23 | 2021-11-18 | 4/A | Diamandis Peter | VAXX | Class A common stock | D | 13,0000 | -248 | -3 | 90.499 | ||||
2022-06-23 | 2021-11-15 | 4/A | Diamandis Peter | VAXX | Class A common stock | D | 13.824 | 13.824 | ||||||
2022-06-23 | 2021-11-15 | 4/A | Diamandis Peter Held by spouse | VAXX | Class A common stock | I | 13.824 | 13.824 | ||||||
2022-06-23 | 2022-01-24 | 4/A | Diamandis Peter | VAXX | Class A common stock | D | 8,6000 | -312.659 | -2.689 | 430.604 | ||||
2022-06-21 | 2022-06-16 | 4 | UNITED BIOMEDICAL INC | VAXX | Class A common stock | D | 1,9929 | 100.000 | 199 | 51.737.344 | ||||
2022-06-21 | 2022-06-16 | 4 | Reese Lou Held by United Biomedical Inc. | VAXX | Class A common stock | I | 1,9929 | 100.000 | 199 | 51.737.344 | ||||
2022-06-21 | 2022-06-16 | 4 | Hu Mei Mei Held by United Biomedical Inc. | VAXX | Class A common stock | I | 1,9929 | 100.000 | 199 | 51.737.344 | ||||
2022-06-14 | 2022-06-13 | 4 | Prime Movers Lab Fund I LP | VAXX | Class A Common Stock | D | 2,4259 | -92.569 | -225 | 9.617.245 | ||||
2022-06-14 | 2022-06-13 | 4 | Prime Movers Lab Fund I LP Held by COVAXX PML SPV 3 LP | VAXX | Class A Common Stock | I | 2,4259 | -14.427 | -35 | 1.498.904 | ||||
2022-06-14 | 2022-06-13 | 4 | Prime Movers Lab Fund I LP Held by COVAXX PML SPV 2 LP | VAXX | Class A Common Stock | I | 2,4259 | -8.193 | -20 | 851.152 | ||||
2022-06-14 | 2022-06-13 | 4 | Prime Movers Lab Fund I LP Held by COVAXX PML SPV 1 LP | VAXX | Class A Common Stock | I | 2,4259 | -21.811 | -53 | 2.265.975 | ||||
2022-06-14 | 2022-06-10 | 4 | Prime Movers Lab Fund I LP | VAXX | Class A Common Stock | D | 2,7981 | -28.378 | -79 | 9.709.814 | ||||
2022-06-14 | 2022-06-10 | 4 | Prime Movers Lab Fund I LP Held by COVAXX PML SPV 3 LP | VAXX | Class A Common Stock | I | 2,7981 | -4.423 | -12 | 1.513.331 | ||||
2022-06-14 | 2022-06-10 | 4 | Prime Movers Lab Fund I LP Held by COVAXX PML SPV 2 LP | VAXX | Class A Common Stock | I | 2,7981 | -2.512 | -7 | 859.345 | ||||
2022-06-14 | 2022-06-10 | 4 | Prime Movers Lab Fund I LP Held by COVAXX PML SPV 1 LP | VAXX | Class A Common Stock | I | 2,7981 | -6.687 | -19 | 2.287.786 | ||||
2022-06-10 | 2022-06-09 | 4 | UNITED BIOMEDICAL INC | VAXX | Class A common stock | D | 2,7193 | 10.978 | 30 | 51.637.344 | ||||
2022-06-10 | 2022-06-08 | 4 | UNITED BIOMEDICAL INC | VAXX | Class A common stock | D | 2,9534 | 10.000 | 30 | 51.626.366 | ||||
2022-06-10 | 2022-06-09 | 4 | Hu Mei Mei Held by United Biomedical Inc. | VAXX | Class A common stock | I | 2,7193 | 10.978 | 30 | 51.637.344 | ||||
2022-06-10 | 2022-06-08 | 4 | Hu Mei Mei Held by United Biomedical Inc. | VAXX | Class A common stock | I | 2,9534 | 10.000 | 30 | 51.626.366 | ||||
2022-06-10 | 2022-06-09 | 4 | Reese Lou Held by United Biomedical Inc. | VAXX | Class A common stock | I | 2,7193 | 10.978 | 30 | 51.637.344 | ||||
2022-06-10 | 2022-06-08 | 4 | Reese Lou Held by United Biomedical Inc. | VAXX | Class A common stock | I | 2,9534 | 10.000 | 30 | 51.626.366 | ||||
2022-05-05 | 2022-05-03 | 4 | Guirakhoo Farshad | VAXX | Stock Option (right to buy) | D | 0,57 | -10.000 | 116.730 | |||||
2022-05-05 | 2022-05-03 | 4 | Guirakhoo Farshad | VAXX | Class A common stock | D | 0,5700 | 10.000 | 6 | 10.000 | ||||
2022-04-28 | 2022-04-27 | 4 | Hu Mei Mei Held by United Biomedical Inc. | VAXX | Class A common stock | I | 3,5826 | 4.807 | 17 | 51.616.366 | ||||
2022-04-28 | 2022-04-26 | 4 | Hu Mei Mei Held by United Biomedical Inc. | VAXX | Class A common stock | I | 3,4503 | 18.105 | 62 | 51.611.559 | ||||
2022-04-28 | 2022-04-27 | 4 | Reese Lou Held by United Biomedical Inc. | VAXX | Class A common stock | I | 3,5826 | 4.807 | 17 | 51.616.366 | ||||
2022-04-28 | 2022-04-26 | 4 | Reese Lou Held by United Biomedical Inc. | VAXX | Class A common stock | I | 3,4503 | 18.105 | 62 | 51.611.559 | ||||
2022-04-28 | 2022-04-27 | 4 | UNITED BIOMEDICAL INC | VAXX | Class A common stock | D | 3,5826 | 4.807 | 17 | 51.616.366 | ||||
2022-04-28 | 2022-04-26 | 4 | UNITED BIOMEDICAL INC | VAXX | Class A common stock | D | 3,4503 | 18.105 | 62 | 51.611.559 | ||||
2022-04-27 | 2022-04-25 | 4 | Hu Mei Mei Held by United Biomedical Inc. | VAXX | Class A common stock | I | 3,3681 | 8.038 | 27 | 51.593.454 | ||||
2022-04-27 | 2022-04-25 | 4 | Reese Lou Held by United Biomedical Inc. | VAXX | Class A common stock | I | 3,3681 | 8.038 | 27 | 51.593.454 | ||||
2022-04-27 | 2022-04-25 | 4 | UNITED BIOMEDICAL INC | VAXX | Class A common stock | D | 3,3681 | 8.038 | 27 | 5.193.454 | ||||
2022-04-04 | 2022-03-31 | 4 | Powchik Peter | VAXX | Stock Option (right to buy) | D | 4,30 | 94.186 | 94.186 | |||||
2022-04-04 | 3 | Powchik Peter | VAXX | Class A common stock | D | 225.858 | ||||||||
2022-03-15 | 2022-03-15 | 4 | Palm Ulo | VAXX | Restricted Stock Units | D | 100.000 | 100.000 | ||||||
2022-01-26 | 2022-01-24 | 4 | Diamandis Peter | VAXX | Stock Option (right to buy) | D | 4,12 | -652.764 | 163.191 | |||||
2022-01-26 | 2022-01-24 | 4 | Diamandis Peter | VAXX | Class A common stock | D | 4,1192 | 652.764 | 2.689 | 729.687 | ||||
2022-01-11 | 2022-01-03 | 4 | Pesile Jason | VAXX | Stock Option (right to buy) | D | 5,96 | 51.225 | 51.225 | |||||
2022-01-06 | 2021-12-31 | 4 | Chui James | VAXX | Class A common stock | D | 5,4800 | 6.000 | 33 | 14.000 | ||||
2022-01-05 | 2022-01-03 | 4 | HORNIG GEORGE R | VAXX | Stock Option (right to buy) | D | 5,96 | 67.953 | 67.953 | |||||
2021-12-14 | 2021-12-10 | 4 | Chui James | VAXX | Class A common stock | D | 7,8900 | 8.000 | 63 | 8.000 | ||||
2021-11-18 | 2021-11-16 | 4 | BLATT GREGORY R | VAXX | Class A common stock | D | 76.923 | 76.923 | ||||||
2021-11-18 | 2021-11-16 | 4 | BLATT GREGORY R Held by Bald Eagle IV LLC | VAXX | Class A common stock | I | -76.923 | 0 | ||||||
2021-11-18 | 2021-11-18 | 4 | Diamandis Peter | VAXX | Class A common stock | D | 76.923 | 76.923 | ||||||
2021-11-18 | 2021-11-18 | 4 | Diamandis Peter Held by Bald Eagle IV LLC | VAXX | Class A common stock | I | -76.923 | 0 | ||||||
2021-11-15 | 2021-11-15 | 4 | Diamandis Peter Held by spouse | VAXX | Series A preferred stock | I | -21.511 | 0 | ||||||
2021-11-15 | 2021-11-15 | 4 | Diamandis Peter Held by Bald Eagle IV LLC | VAXX | Class A common stock | I | 76.923 | 76.923 | ||||||
2021-11-15 | 2021-11-15 | 4 | Diamandis Peter Held by spouse | VAXX | Class A common stock | I | 271.655 | 271.655 | ||||||
2021-11-15 | 2021-11-15 | 4 | BLATT GREGORY R Held by The Gregory R. Blatt 2020 Annuity Trust III | VAXX | Series B preferred stock | I | -250.000 | 0 | ||||||
2021-11-15 | 2021-11-15 | 4 | BLATT GREGORY R Held by The Gregory R. Blatt 2020 Annuity Trust IX | VAXX | Series A preferred stock | I | -83.329 | 0 | ||||||
2021-11-15 | 2021-11-15 | 4 | BLATT GREGORY R Held by Blatt Family Investments LLC | VAXX | Series A preferred stock | I | -968.636 | 0 | ||||||
2021-11-15 | 2021-11-15 | 4 | BLATT GREGORY R Held by Bald Eagle IV LLC | VAXX | Class A common stock | I | 76.923 | 76.923 | ||||||
2021-11-15 | 2021-11-15 | 4 | BLATT GREGORY R Held by The Gregory R. Blatt 2020 Annuity Trust III | VAXX | Class A common stock | I | 160.668 | 160.668 | ||||||
2021-11-15 | 2021-11-15 | 4 | BLATT GREGORY R Held by The Gregory R. Blatt 2020 Annuity Trust IX | VAXX | Class A common stock | I | 53.553 | 53.553 | ||||||
2021-11-15 | 2021-11-15 | 4 | BLATT GREGORY R Held by Blatt Family Investments LLC | VAXX | Class A common stock | I | 622.516 | 622.516 | ||||||
2021-11-15 | 2021-11-11 | 4 | Guirakhoo Farshad | VAXX | Stock option (right to buy) | D | 13,00 | 41.958 | 41.958 | |||||
2021-11-15 | 2021-11-11 | 4 | Paula Molina Rene | VAXX | Stock option (right to buy) | D | 13,00 | 96.153 | 96.153 | |||||
2021-11-15 | 2021-11-15 | 4 | Reese Lou Held by United Biomedical Inc., Asia | VAXX | Series A preferred stock | I | -6.554.643 | 0 | ||||||
2021-11-15 | 2021-11-15 | 4 | Reese Lou Held by United Biomedical Inc. | VAXX | Series A preferred stock | I | -384.410 | 0 | ||||||
2021-11-15 | 2021-11-15 | 4 | Reese Lou Held by Blackfoot Healthcare Ventures LLC | VAXX | Series A preferred stock | I | -422.696 | 0 | ||||||
2021-11-15 | 2021-11-15 | 4 | Reese Lou Held by United Biomedical Inc., Asia | VAXX | Class A common stock | I | 4.212.495 | 4.212.495 | ||||||
2021-11-15 | 2021-11-15 | 4 | Reese Lou Held by United Biomedical Inc. | VAXX | Class A common stock | I | 247.050 | 51.585.416 | ||||||
2021-11-15 | 2021-11-15 | 4 | Reese Lou Held by Blackfoot Healthcare Ventures LLC | VAXX | Class A common stock | I | 271.655 | 271.655 | ||||||
2021-11-15 | 2021-11-12 | 4 | Reese Lou | VAXX | Class A common stock | D | 13,8240 | 17.500 | 242 | 17.500 | ||||
2021-11-15 | 2021-11-15 | 4 | Palm Ulo Held by spouse | VAXX | Class A common stock | I | 13,0000 | 450 | 6 | 450 | ||||
2021-11-15 | 2021-11-11 | 4 | Palm Ulo | VAXX | Stock option (right to buy) | D | 13,00 | 233.100 | 233.100 | |||||
2021-11-15 | 2021-11-15 | 4 | Hu Mei Mei Held by United Biomedical Inc., Asia | VAXX | Series A preferred stock | I | -6.554.643 | 0 | ||||||
2021-11-15 | 2021-11-15 | 4 | Hu Mei Mei Held by United Biomedical Inc. | VAXX | Series A preferred stock | I | -384.410 | 0 | ||||||
2021-11-15 | 2021-11-15 | 4 | Hu Mei Mei Held by Blackfoot Healthcare Ventures LLC | VAXX | Series A preferred stock | I | -422.696 | 0 | ||||||
2021-11-15 | 2021-11-15 | 4 | Hu Mei Mei Held by United Biomedical Inc., Asia | VAXX | Class A common stock | I | 4.212.495 | 4.212.495 | ||||||
2021-11-15 | 2021-11-15 | 4 | Hu Mei Mei Held by United Biomedical Inc. | VAXX | Class A common stock | I | 247.050 | 51.585.416 | ||||||
2021-11-15 | 2021-11-15 | 4 | Hu Mei Mei Held by Blackfoot Healthcare Ventures LLC | VAXX | Class A common stock | I | 271.655 | 271.655 | ||||||
2021-11-15 | 2021-11-12 | 4 | Hu Mei Mei Held by spouse | VAXX | Class A common stock | I | 13,8240 | 17.500 | 242 | 17.500 | ||||
2021-11-15 | 2021-11-15 | 4 | UNITED BIOMEDICAL INC Held by United Biomedical Inc., Asia | VAXX | Series A preferred stock | I | -6.554.643 | 0 | ||||||
2021-11-15 | 2021-11-15 | 4 | UNITED BIOMEDICAL INC | VAXX | Series A preferred stock | D | -384.410 | 0 | ||||||
2021-11-15 | 2021-11-15 | 4 | UNITED BIOMEDICAL INC Held by United Biomedical Inc., Asia | VAXX | Class A common stock | I | 4.212.495 | 4.212.495 | ||||||
2021-11-15 | 2021-11-15 | 4 | UNITED BIOMEDICAL INC | VAXX | Class A common stock | D | 247.050 | 51.585.416 | ||||||
2021-11-15 | 2021-11-15 | 4 | Prime Movers Lab Fund I LP | VAXX | Series A preferred stock | D | -15.152.627 | 0 | ||||||
2021-11-15 | 2021-11-15 | 4 | Prime Movers Lab Fund I LP Held by Prime Movers Growth Fund 1 LP | VAXX | Series B preferred stock | I | -5.625.000 | 0 | ||||||
2021-11-15 | 2021-11-15 | 4 | Prime Movers Lab Fund I LP Held by COVAXX PML SPV 3 LP | VAXX | Series A preferred stock | I | -2.361.626 | 0 | ||||||
2021-11-15 | 2021-11-15 | 4 | Prime Movers Lab Fund I LP Held by COVAXX PML SPV 2 LP | VAXX | Series A preferred stock | I | -1.341.050 | 0 | ||||||
2021-11-15 | 2021-11-15 | 4 | Prime Movers Lab Fund I LP Held by COVAXX PML SPV 1 LP | VAXX | Series A preferred stock | I | -3.570.201 | 0 | ||||||
2021-11-15 | 2021-11-15 | 4 | Prime Movers Lab Fund I LP | VAXX | Class A common stock | D | 9.738.192 | 9.738.192 | ||||||
2021-11-15 | 2021-11-15 | 4 | Prime Movers Lab Fund I LP Held by Prime Movers Growth Fund 1 LP | VAXX | Class A common stock | I | 3.615.038 | 3.615.038 | ||||||
2021-11-15 | 2021-11-15 | 4 | Prime Movers Lab Fund I LP Held by COVAXX PML SPV 3 LP | VAXX | Class A common stock | I | 1.517.754 | 1.517.754 | ||||||
2021-11-15 | 2021-11-15 | 4 | Prime Movers Lab Fund I LP Held by COVAXX PML SPV 2 LP | VAXX | Class A common stock | I | 861.857 | 861.857 | ||||||
2021-11-15 | 2021-11-15 | 4 | Prime Movers Lab Fund I LP Held by COVAXX PML SPV 1 LP | VAXX | Class A common stock | I | 2.294.473 | 2.294.473 | ||||||
2021-11-10 | 3 | UNITED BIOMEDICAL INC | VAXX | Class A common stock | D | 51.338.366 | ||||||||
2021-11-10 | 3 | Doran Martin | VAXX | Class A common stock | D | 22.688 | ||||||||
2021-11-10 | 3 | Hu Mei Mei Held by United Biomedical Inc. See Note | VAXX | Class A common stock | I | 51.338.366 | ||||||||
2021-11-10 | 3 | Hu Mei Mei Held by spouse. See Note | VAXX | Class B common stock | I | 3.955.512 | ||||||||
2021-11-10 | 3 | Hu Mei Mei | VAXX | Class B common stock | D | 5.518.961 | ||||||||
2021-11-10 | 3 | Diamandis Peter | VAXX | Class B common stock | D | 1.099.915 | ||||||||
2021-11-10 | 3 | Reese Lou Held by spouse. See Note | VAXX | Class B common stock | I | 5.518.961 | ||||||||
2021-11-10 | 3 | Reese Lou | VAXX | Class B common stock | D | 3.955.511 | ||||||||
2021-11-10 | 3 | Reese Lou Held by United Biomedical Inc. See Note | VAXX | Class A common stock | I | 51.338.366 |